Veneto is an asset that can produce no revenue. A
Post# of 36537
(Total Views: 528)
Posted On: 04/17/2019 3:57:47 AM
Veneto is an asset that can produce no revenue. A MSO needs services, members and a solid reputation. You have none of these. The pharmacies acquired are closed. High Desert Diagnostic Lab is closed. Do you even know if you have members in an MSO? As for the the "leadership" with the "secret sauce", it appears they are gone (good riddance but yet still getting paid). So much for intangibles and goodwill.
Just curious but how will Generex create revenue now that you know the Veneto business model is dead and that there is no leadership, employees or assets to carry out the plan?
Why do they keep telling you this was a good buy?
How will Generex make more acquisitions or hire more lawyers without revenue?
p.s. You can't exclude MHS otherwise known as Medoc Health Services because of the investigations but also still count them in for the revenue generating portion of the business. (although it now looks like they have finally acknowledged that it is "the company" including all entities, that are subject to the investigation, not just Medoc)
Don't be fooled. A 2+ year joint investigation that is still continuing involving the OIG, DEA, FBI, Pharmacy Board and several other agencies is significant and not in the "early stages". People will be going to jail. Lots of money will be owed.
You are not being told the whole story. Read every line and question it all. They have misconstrued/left out significant information with every version. I know you can see that the story keeps changing every time they are put under the microscope. So much for transparency. This is either really shoddy DD and business accumen or just maybe they never intended to tell the whole story unless they got called out on it.
Just curious but how will Generex create revenue now that you know the Veneto business model is dead and that there is no leadership, employees or assets to carry out the plan?
Why do they keep telling you this was a good buy?
How will Generex make more acquisitions or hire more lawyers without revenue?
p.s. You can't exclude MHS otherwise known as Medoc Health Services because of the investigations but also still count them in for the revenue generating portion of the business. (although it now looks like they have finally acknowledged that it is "the company" including all entities, that are subject to the investigation, not just Medoc)
Don't be fooled. A 2+ year joint investigation that is still continuing involving the OIG, DEA, FBI, Pharmacy Board and several other agencies is significant and not in the "early stages". People will be going to jail. Lots of money will be owed.
You are not being told the whole story. Read every line and question it all. They have misconstrued/left out significant information with every version. I know you can see that the story keeps changing every time they are put under the microscope. So much for transparency. This is either really shoddy DD and business accumen or just maybe they never intended to tell the whole story unless they got called out on it.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼